Meeting of the Scandinavian Sarcoma Group

Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience.

Results from four consecutive trials, conducted from 1982 by members of the Scandinavian Sarcoma Group, are reviewed. A total of 330 classical osteosarcoma patients were enrolled. In all trials chemotherapy was based on the three active drugs, methotrexate, doxorubicin and cisplatinum and for the latter trials also ifosfamide. Post-operative chemotherapy was stratified by histological response ...

The Scandinavian Sarcoma Group experience

Evaluation of urban management and political Scandinavian economy (case study: Sweden and Norway)

Study on international political economy of two countries, Sweden and Norway, in international interactions allows us to examine political economy of these two countries as the case study for further understanding of macro patterns of international political economy.  Thus, understanding the power of influence of international developments in two economic and political areas in internal relatio...

The Scandinavian Sarcoma Group--background, organization and the SSG Register--the first 25 years.

May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.

The aim was to evaluate the clinical impact of P-glycoprotein in primary non-metastatic high-grade osteosarcoma patients, treated with neoadjuvant chemotherapy protocols. P-glycoprotein was assessed by immunohistochemistry on paraffin-embedded tissue samples collected at time of diagnosis from 94 osteosarcoma patients, treated with the Italian Sarcoma Group/Scandinavian Sarcoma Group 1 (ISG/SSG...